Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow 0.00% Nasdaq Up0.52%

More On QLT.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


QLT Inc. (QLT.TO)

-Toronto
6.83 Up 0.27(4.12%) Apr 24
Get the big picture on all your investments.
ProfileGet Profile for:
QLT Inc.
887 Great Northern Way
Suite 101
Vancouver, BC V5T 4T5
Canada - Map
Phone: 604-707-7000
Fax: 604-707-7001
Website: http://www.qltinc.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:37

Business Summary 

QLT Inc., a biotechnology company, develops and commercializes ocular products that address the unmet medical needs of patients and clinicians worldwide. It focuses on the development of QLT091001, a synthetic retinoid compound, which is in phase Ib retreatment clinical trials for the treatment of leber congenital amaurosis and retinitis pigmentosa; phase Ib clinical trials for the treatment of Retinitis Pigmentosa with autosomal dominant mutation in RPE65; and phase IIa clinical trials for the treatment of impaired dark adaptation. The company was founded in 1981 and is headquartered in Vancouver, Canada.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on QLT Inc.

Key Executives 
 PayExercised
Mr. Jeffrey A. Meckler , 47
Principal Exec. Officer, Independent Director, Chairman of Exec. Transition Committee and Member of Strategic Action Committee
159.00KN/A
Mr. Sukhi Jagpal , 40
Chief Financial Officer and Principal Accounting Officer
280.00K219.00K
Dr. Alexander R. Lussow Ph.D., 52
Sr. VP of Bus. Devel. and Commercial Operations
590.00K1.08M
Dr. Sushanta Mallick Ph.D.,
VP of R&D
N/AN/A
Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in CAD.